Display options
Cite
Gorski DH, Novella SP. Considering prior plausibility in clinical trials does not mean ignoring scientific evidence. Trends Mol Med. 2014;20(11):600-1doi: 10.1016/j.molmed.2014.10.001.
Gorski, D. H., & Novella, S. P. (2014). Considering prior plausibility in clinical trials does not mean ignoring scientific evidence. Trends in molecular medicine, 20(11), 600-1. https://doi.org/10.1016/j.molmed.2014.10.001
Gorski, David H, and Novella, Steven P. "Considering prior plausibility in clinical trials does not mean ignoring scientific evidence." Trends in molecular medicine vol. 20,11 (2014): 600-1. doi: https://doi.org/10.1016/j.molmed.2014.10.001
Gorski DH, Novella SP. Considering prior plausibility in clinical trials does not mean ignoring scientific evidence. Trends Mol Med. 2014 Nov;20(11):600-1. doi: 10.1016/j.molmed.2014.10.001. Epub 2014 Oct 17. PMID: 25439966.
Copy Download .nbib Format: NLM
Share it on

Trends Mol Med. 2014 Nov;20(11):600-1. doi: 10.1016/j.molmed.2014.10.001. Epub 2014 Oct 17.

Considering prior plausibility in clinical trials does not mean ignoring scientific evidence.

Trends in molecular medicine

David H Gorski, Steven P Novella

Affiliations

  1. Michael and Marian Illitch Department of Surgery, Wayne State University School of Medicine, 3990 John R St., Detroit, MI 48201, USA; Molecular Therapeutics Program, Wayne State University, Barbara Ann Karmanos Cancer Institute, 4100 John R St., Detroit, MI 48201, USA. Electronic address: [email protected].
  2. Department of Neurology, Yale University, 40 Temple St., Suite 6C, New Haven CT 06510, USA.

PMID: 25439966 DOI: 10.1016/j.molmed.2014.10.001

[No abstract available.]

Keywords: clinical trials; complementary and alternative medicine; evidence-based medicine; integrative medicine; science-based medicine

MeSH terms

Publication Types